is glp 1 patented How to Survive the GLP-1 Patent War: A Strategic Manual for 503B Outsourcing Facilities Competing in the Post-Patent GLP-1
Description
Gala GLP-1 is designed for adults 18 years of age or older with high BMI, obesity, or weight-related health concerns
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial Lau DCW, Erichsen L, Francisco-Ziller N, et al
High Percentage of Responders: Over 30% of subjects on the 2.4 mg dose achieved 20% or more weight loss at 48 weeks
A false page claiming to be the TGA itself has even sprung up
The medication is not the enemy
